Kristiina Maria Huttunen | Nanobiotechnology | Best Researcher Award

Posted on by ScienceFather
Assoc Prof Dr. Kristiina Maria Huttunen: Nanobiotechnology

Dr. Kristiina Maria Huttunen, born on May 7, 1980, in Taipalsaari, Finland, is an accomplished researcher specializing in drug targeting and nanochemistry. A native Finnish speaker with excellent proficiency in English, and proficiency in Swedish and basic skills in German, she is an Associate Professor at the University of Eastern Finland (UEF), leading the Transporter-mediated Drug Delivery group.

🎓 Education:

Docent Drug Targeting (Adjunct/Associate Professor): University of Eastern Finland, 2015. Ph.D. in Pharmaceutical Chemistry: University of Kuopio, 2009 (Best Thesis of the University 2008-2009). M.Sc. in Medicinal Chemistry: University of Kuopio, 2004. B.Sc. in Chemistry: University of Jyväskylä, 2003

👩‍🏫 Teaching & Continuing Education:

Course Director for Organic Chemistry (from 2023). Various teaching roles since 2005. Continued education in leadership and pedagogy.

🏢 Current Position (in Finland):

University: University of Eastern Finland. Faculty: Faculty of Health Sciences, School of Pharmacy. Position: Associate Professor (Tenure Track) and Principal Investigator (PI). Group: Leader of Transporter-mediated Drug Delivery Group (9 members). Commencement: 1st December 2023.

📚 Previous Work Experience:

Research Director, University Researcher, and Academy Research Fellow at UEF. Postdoctoral Research positions in Finland and New Zealand. Research Scientist and Ph.D. Student at the University of Kuopio.

👩‍🔬 Supervision & Teaching Experience:

Supervised numerous graduate and undergraduate students. Diverse teaching roles in organic chemistry and pharmaceutical courses.

💰 Research Funding:

PI for Project Grants totaling €3,060,733. Supervised student grants totaling €612,757. Postdoctoral and Ph.D. student grants.

👩‍💼 Institutional Responsibilities and Commissions of Trust:

Board Member, Faculty Council, and Doctoral Programme in Drug Research. Active involvement in brain barrier and brain tumor research associations. Reviewer for scientific journals and external reviewer for research plan defenses.

🔍 Scientific and Societal Impact (2004 – present):

77 Peer-reviewed original publications, 16 review articles. Invited speaker at 20 national/international conferences and seminars. Webpages and blog for open science communication. Patents and invention disclosures. Extensive engagement in general audience publications and interviews.

Professional Profiles:

The impact of her research is evident in citation metrics and indices from Google Scholar:

  • Cited by: All – 2,401.
  • Citations – 1595.
  • h-index – 24.
  • Documents – 98.

A prolific researcher making meaningful contributions to the academic world!

Research Focus:

Dr. Assoc Prof Dr. Kristiina Maria Huttunen research revolves around understanding brain barrier transporters and their role in drug delivery. Their work spans the structural comparison of sulfonamide-based derivatives, exploration of experimental strategies for studying amino acid transporter utilization, and the intricate relationship between neurosteroids and organic anion transporting polypeptides (OATP)1A2.

Publications Top Note:

 

 

Nanobio Innovation Recognition

Posted on by ScienceFather

Introduction of Nanobio Innovation Recognition

Welcome to the forefront of biological innovation at the Nanobio Innovation Recognition. This distinguished award celebrates trailblazers who have significantly contributed to the convergence of nanotechnology and the life sciences, driving breakthroughs in biomedicine, diagnostics, and beyond.

Award Eligibility:

The Nanobio Innovation Recognition is open to researchers, scientists, and innovators globally. There are no age limits, and applicants should demonstrate a commitment to advancing the field of nanobiotechnology through their pioneering work.

Qualification and Publications:

Applicants should hold a minimum of a bachelor’s degree in a relevant field and showcase their commitment through impactful publications, patents, or innovations that highlight their expertise in the intersection of nanotechnology and the life sciences.

Recurrence:

This award is an annual recognition, providing a recurring platform for innovators to showcase their ongoing contributions to the dynamic field of nanobio innovation.

Evaluation Criteria:

Candidates will be evaluated based on the impact, originality, and transformative nature of their work in nanobiotechnology. Judges will assess the significance of their contributions to biomedicine, diagnostics, and other areas where nanotechnology intersects with the life sciences.

Submission Guidelines:

Detailed submission guidelines can be found on our official website. Applicants are required to submit a comprehensive biography, an abstract outlining their nanobio innovations, and supporting files that illustrate the impact and potential of their groundbreaking work.

Recognition:

Recipients of the Nanobio Innovation Recognition will receive global recognition for their outstanding contributions, including features in leading scientific publications and invitations to exclusive events in the nanobiotechnology community.

Community Impact:

Beyond personal recognition, the award aims to amplify the community impact of nanobio innovators by fostering collaboration and knowledge exchange among researchers, scientists, and industry leaders.

Biography, Abstract, and Supporting Files:

Applicants are encouraged to provide a detailed biography showcasing their journey in nanobio innovation. The abstract should succinctly summarize key innovations and their impact on biomedicine, diagnostics, or other relevant fields. Supporting files, such as research papers, patent documents, or testimonials, can be submitted to enhance the understanding of their contributions.